Preclinical Medical Cannabis Research
![](/remote/aHR0cHM6Ly9naWVjZG4uYmxvYi5jb3JlLndpbmRvd3MubmV0L2ZpbGV1cGxvYWRzL2ltYWdlLzIwMjQvMDcvMDkvcmFwaGFlbC5waGFybWFjZXV0aWNhbC5wbmc.HnK9CLGUi_Q.png?w=948&h=533&format=webp&mode=pad&anchor=middlecenter&scale=both&bgcolor=F0F1F2)
Raphael Pharmaceutical Issues Letter to Shareholders
The letter highlights the company’s exclusive relationship with Rambam Health Care Campus, differentiated cannabinoid-based technology platform, promising lead product candidate for rheumatoid arthritis, recently commenced clinical study, broader pipeline opportunities, and overall mission and vision.